Micropharma Limited Report issue

For profit Phase 1 Phase 2
Founded: Montreal QE Canada (2004)
Status: Acquired by UAS Labs LLC (2017) → now Novonesis (2023)

Organization Overview

First Clinical Trial
2007
NCT01409668
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

lactobacillus reuteri (4 trials)

Drugs in Phase 1 Trials (2)

Lactobacillus amylovorus (1 trial)

lactobacillus fermentum (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypercholesterolemia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 5
  • # of Trial APIs: 3